By Clifford Hwang
Perhaps it is due to the long hours that tax attorneys have put in at the office these past two weeks since the Treasury Department introduced new tax-inversion rules, but it finally seems that there may be clarification of these rules soon. These tax-inversion rules, which were introduced on April 4, had threatened to curb some cross-border mergers and did curb the Pfizer-Allergan deal. The rules will hopefully be clarified as Canada’s Mitel Networks Corp attempts to merge with the U.S.’s Polycom Inc. for $1.96 billion, which is anticipated to present significant tax savings. Perhaps the Treasury will offer even more guidance if and when someone files suit against the administration to challenge this rule.